Advances in Nuclear Medicine & Molecular Imaging 2024 (Videos)

Advances in Nuclear Medicine and Molecular Imaging features fourteen internationally renowned faculty experts discussing nuclear medicine’s latest trends and emerging procedures.  Created from the Mid-Eastern Chapter of the Society of Nuclear Medicine and Molecular Imaging’s 52nd Annual Conference, this activity presents the impact of radiopharmaceuticals on imaging, cardiology, oncology and much more.  Robust discussions of imaging tools, administration equipment, dosimetry and future applications are included, as well.

Topics 

Advances in Nuclear Medicine & Molecular Imaging
Developing a PET-CT RB-82 Myocardial Imaging Program	Jason Jenkins, CNMT
Rb-82 PET Myocardial Blood Flow Imaging	Jason Jenkins, CNMT
Molecular Imaging With PET to Detect and Quantify Atherosclerotic Plaques	Abass Alavi, MD
Session 2: Dosimetry
Dosimetry Basics	Carlos Uribe, PhD
Personalized dosimetry for Y90 TARE	Kevin Hirsch, MD
Advanced Dosimetry Including Use in the Theranostics Routine	Michael Morris, MD
Session 3: Oncologic Imaging
Can Radiotracer Based Bone Scanning to Detect Metastasis Survive the Test of Time	Abass Alavi, MD
Lymphoma Staging and Response Assessment: Past, Present and Future	Bruce Cheson, MD
Recent Developments and Issues in Differentiated Thyroid Cancer	Douglas Van Nostrand, MD
PET/CT in Brain Tumors: Current and Potential Future Applications	Mohammed Gharavi, MD
Systemic Therapy in Advanced Prostate Cancer: The Evolving Landscape	Asit Paul, PhD
Session 4: Radiation Safety & SPECT-CT
Radiation Safety in the Age of Theranostics	Jayashree Parekh, MD
Our Quest for Ultra Low Dose PET-CT Scanning: Experience and Implications	Eliot Siegel, MD
Panel Discussion	Multiple Faculty
Benefits of SPECT-CT	Gabriel Soudry, MD
Session 5: Future Applications
Hype, Reality, and the Future Potential of AI in Nuclear Medicine	Eliot Siegel, MD
Current and Emerging Radiopharmaceuticals in Theranostics	Joseph Osborne, MD
Expanding the Practice of Lu177 Based Radiopharmaceutical Therapies From a Tertiary Care Hospital to the Community: Opportunities and Challenges	Giuseppe Esposito, MD
PET Imaging’s Impact on Medicine, Research and Future Options	Abass Alavi, MD